MOH — authorised 13 March 2013
- Marketing authorisation holder: NAVIDEA BIOPHARMS
- Status: likely_approved
MOH authorised Lymphoseek Kit on 13 March 2013
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 13 March 2013.
NAVIDEA BIOPHARMS holds the UAE marketing authorisation.